Use of sodium-glucose co-transporter-2 inhibitors from clinical trial results to practical application in Russia

Por D. A. Lebedev, A. Yu. Babenko
Publicado em 2018-09-01

Fibrosis biomarkers and echocardiographic parameters in patients with type 2 diabetes depending on the degree of albuminuria

Por D. A. Lebedev, M. Yu. Laevskaya, A. Yu. Babenko
Publicado em 2021-10-01

Evaluation of factors influencing adherence to treatment with sodium-glucose cotransporter type 2 inhibitor

Por D. A. Lebedev, A. A. Mosikian, A. Yu. Babenko
Publicado em 2020-10-01

LONG-TERM RESULTS OF ORGANOSAFE OPERATION IN OBSTRUCTIVE URETEROHYDRONEPHROSIS OF TERMINAL STAGE

Por I. B. Osipov, D. A. Lebedev, A. A. Fedotkina
Publicado em 2018-01-01

Kidney triplication with ectopic ureterocele: a case report

Por I. B. Osipov, D. A. Lebedev, M. V. Lifanova
Publicado em 2020-05-01

Molecular biomarker profile of heart failure with mid-range and preserved ejection fraction in patients with type 2 diabetes

Por D. A. Lebedev, E. A. Lyasnikova, A. A. Vasilyeva, E. Yu. Vasilyeva, A. Yu. Babenko, E. V. Shlyakhto
Publicado em 2020-11-01

A Multidisciplinary Approach to the Treatment of COVID-Associated Complications After Pancreatoduodenal Resection (Case Report)

Por T. E. Kim, D. A. Lebedev, M. M. Magomedbekov, K. A. Nugumanova, S. S. Petrikov, K. A. Popugayev, M. L. Rogal, P. A. Yartsev
Publicado em 2021-11-01